BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30068596)

  • 21. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
    Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
    Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GIFT4 fusokine converts leukemic B cells into immune helper cells.
    Deng J; Pennati A; Cohen JB; Wu Y; Ng S; Wu JH; Flowers CR; Galipeau J
    J Transl Med; 2016 Apr; 14(1):106. PubMed ID: 27118475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.
    Heerema NA; Byrd JC; Dal Cin PS; Dell' Aquila ML; Koduru PR; Aviram A; Smoley SA; Rassenti LZ; Greaves AW; Brown JR; Rai KR; Kipps TJ; Kay NE; Van Dyke DL;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):134-40. PubMed ID: 21156225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo.
    Dampmann M; Görgens A; Möllmann M; Murke F; Dührsen U; Giebel B; Dürig J
    PLoS One; 2020; 15(2):e0228674. PubMed ID: 32040489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
    Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
    J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells.
    Shcherbina V; Gordiienko I; Shlapatska L; Gluzman D; Sidorenko S
    Neoplasma; 2021 Jul; 68(4):760-769. PubMed ID: 33904315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Tarnani M; Laurenti L; Longo PG; Piccirillo N; Gobessi S; Mannocci A; Marietti S; Sica S; Leone G; Efremov DG
    Leuk Res; 2010 Sep; 34(9):1189-94. PubMed ID: 20074801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
    de Totero D; Meazza R; Zupo S; Cutrona G; Matis S; Colombo M; Balleari E; Pierri I; Fabbi M; Capaia M; Azzarone B; Gobbi M; Ferrarini M; Ferrini S
    Blood; 2006 May; 107(9):3708-15. PubMed ID: 16391014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of chronic lymphocytic leukemia.
    Zhang S; Kipps TJ
    Annu Rev Pathol; 2014; 9():103-18. PubMed ID: 23987584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
    Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
    Krenn PW; Hofbauer SW; Pucher S; Hutterer E; Hinterseer E; Denk U; Asslaber D; Ganghammer S; Sternberg C; Neureiter D; Aberger F; Wickström SA; Egle A; Greil R; Hartmann TN
    Cancer Res; 2016 Apr; 76(8):2186-96. PubMed ID: 26837762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetics of chronic lymphocytic leukemia stimulated by CpG-oligodeoxynucleotides and IL-2].
    Wang DM; Xu W; Dong HJ; Fang C; Zhu DX; Cao X; Zhu HY; Zhuang Y; Qiu HR; Yang H; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1114-8. PubMed ID: 21129242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
    Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
    Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
    Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
    J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.
    Kay NE; Han L; Bone N; Williams G
    Br J Haematol; 2001 Mar; 112(3):760-7. PubMed ID: 11260081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
    Gowda A; Ramanunni A; Cheney C; Rozewski D; Kindsvogel W; Lehman A; Jarjoura D; Caligiuri M; Byrd JC; Muthusamy N
    MAbs; 2010; 2(1):35-41. PubMed ID: 20081380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
    Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
    J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia].
    Mai DI Na AEK; Liu H; Wang YL; Wang YC; Huang Q; Wang ZS; Gu ZLNE; Lang T; Nie YL; An L; A ZGL; Mu HTBE; Zhang XY; Fu L; Ai HMJ; Mao M; Wang XM; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):470-475. PubMed ID: 32319381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.